Jackson Thornton Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
12,006
-727
-6% -$85.1K 0.12% 49
2026
Q1
$1.55M Sell
12,733
-107
-0.8% -$12.4K 0.14% 41
2025
Q4
$1.4M Buy
12,840
+433
+3% +$40.6K 0.13% 43
2025
Q3
$1.07M Buy
12,407
+8,730
+237% +$719K 0.11% 45
2025
Q2
$299K Buy
3,677
+688
+23% +$54.7K 0.03% 82
2025
Q1
$233K Buy
2,989
+596
+25% +$55.6K 0.03% 82
2024
Q4
$238K Buy
+2,393
New +$247K 0.03% 71

Other funds holding MRK

Jackson Thornton Wealth Management's MRK Position: Q2 2026 in Review

Jackson Thornton Wealth Management reduced its Merck (MRK) stake by 5.7% in Q2 2026, selling an estimated $85.1K and leaving 12,006 shares worth $1.54M. The position accounts for 0.12% of the portfolio, ranked #49.

Jackson Thornton Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.55M in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Jackson Thornton Wealth Management held 12,006 shares of Merck worth $1.54M as of Q2 2026.
  • Jackson Thornton Wealth Management sold 727 Merck shares in Q2 2026, an estimated $85.1K.
  • Merck made up 0.12% of Jackson Thornton Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Jackson Thornton Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Jackson Thornton Wealth Management's Merck position peaked at $1.55M in Q1 2026.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.